NEWS

Canada adult-use cannabis business-to-business net revenue up 9% year-over-year; Canada medical cannabis net revenue up 11% year-over-year Focused execution drove sustained margin improvement with second quarter of consolidated gross margins exceeding 30% Canopy USA strategy moving forward; special shareholder meeting scheduled for April 12, 2024 Read the full PDF Press Release Here SMITHS FALLS, ON, February 9, 2024 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (Nasdaq: CGC) today announces its financial results for the third quarter ended December 31, 2023. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. Highlights…

Smiths Falls, ON, January 26, 2024 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the third quarter fiscal year 2024 ended December 31, 2023 before financial markets open on February 9, 2024. Following the release of its third quarter fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on February 9, at 10AM Eastern Time. Webcast Information A live audio webcast will be available at: https://app.webinar.net/GZqr9ALP1XV Replay Information A replay will be accessible by webcast until 11:59 PM ET on…

SMITHS FALLS, ON, January 24, 2024 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of new product offerings across the Company’s adult use and medical cannabis portfolio, including new Tweed softgels and oils featuring minor cannabinoids, a large format flower offering from Tweed, as well as new medical exclusive pre-roll products from 7ACRES and Spectrum Therapeutics. “In addition to launching new flower products, we’re making it easier to access CBD and minor cannabinoids in convenient oil and softgel formats to support wellness-minded consumers looking to start the…

SMITHS FALLS, ON. January 18, 2024 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), today announced that it has entered into subscription agreements (the “Subscription Agreements”), dated as of January 18, 2024, with certain institutional investors (the “Investors”) in a private placement offering (the “Offering”) of 8,158,510 units (“Units”) at a price per Unit of US$4.29 for aggregate gross proceeds of approximately US$35 million. The purpose of the Offering is to provide the Company with additional liquidity to further strengthen Canopy Growth’s financial position. Proceeds are expected to be used to pay down debt, which…

SMITHS FALLS, ON. January 9, 2024 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), today announced that it has entered into subscription agreements (the “Subscription Agreements”), dated as of January 9, 2024, with certain institutional investors (the “Investors”) in a private placement offering (the “Offering”) of 6,993,007 units (“Units”) at a price per Unit of US$4.29 for aggregate gross proceeds of approximately US$30,000,000 The purpose of the Offering is to provide the Company with additional liquidity of US$30MM to further strengthen Canopy Growth’s financial position. Proceeds are expected to be used to pay down debt,…

Divestiture of the skincare and wellness brand is aligned with Canopy Growth’s focus on North American cannabis operations SMITHS FALLS, ON and LONDON, UK – December 18th, 2023 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) today announced that the Company has completed the divestiture of its This Works skincare and wellness brand to Inspirit Capital, a London-based investment firm. Headquartered in London, England, This Works offers a range of high-quality natural skincare and sleep solution products to consumers around the world. In accordance with the completed sale agreement, This Works’ leadership, staff, and intellectual…

Shares will be consolidated at a 1 for 10 ratio Action expected to allow the Company to regain compliance with Nasdaq minimum bid price requirement SMITHS FALLS, ON — December 13, 2023 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) announced today that the Company’s board of directors has approved the consolidation (the “Consolidation”) of the Company’s issued and outstanding common shares (the “Common Shares”) on the basis of one (1) post-Consolidation Common Share for every ten (10) pre-Consolidation Common Shares. The Consolidation is being implemented to ensure that the Company continues to comply with…

Realization of sale proceeds further strengthens Canopy Growth’s balance sheet Completed transactions further advances Canopy Growth’s cannabis-focused, asset-light operating model SMITHS FALLS, ON – December 1, 2023 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) today provided an update that pursuant to the proceedings under the Companies’ Creditors Arrangement Act (the “CCAA”) involving BioSteel Sports Nutrition Inc. (“BioSteel Canada”), that two sale transactions transferring the assets of BioSteel Canada and BioSteel Manufacturing, LLC (“BioSteel Manufacturing”) have been completed for aggregate gross proceeds of $30.4 million. Pursuant to the CCAA court-ordered sale and investment solicitation process,…

Sleep CBD, Chill CBD, and Extra Strength CBD Gummies Expand Martha’s Evolving Wellness Assortment SMITHS FALLS, ON & NEW YORK, NY, Nov. 29, 2023 – Sleep deprived? Stressed? Sore? Martha Stewart has a CBD gummy for that! Just in time for the holidays, Martha Stewart CBD has unveiled a new line of need-based CBD gummies, broadening the brand’s evolving wellness assortment. Martha Stewart CBD products provide consumers with convenient, plant-based solutions to help people feel their best all day, every day. The new line was developed in response to consumer demand for targeted solutions that address their most common…

Canopy Growth Reports Second Quarter Fiscal Year 2024 Financial Results Strong execution drove significant improvement in gross margins and reduced cash burn in Q2 FY2024 Management reaffirms expectation to achieve positive Adjusted EBITDA in all business units exiting FY2024 Solidified foundation expected to deliver profitable growth and achieve sustainable cannabis market leadership SMITHS FALLS, ON, November 9, 2023 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (Nasdaq: CGC) today announces its financial results for the second quarter ended September 30, 2023. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. Highlights…

Court approves combination of transactions resulting in the sale of all or substantially all of the assets of Biosteel Canada and Biosteel Manufacturing Elimination of funding obligation to BioSteel consistent with Canopy Growth’s cannabis focus and transformation to a simplified, asset-light operating model. SMITHS FALLS, ON – November 17, 2023 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) today provided an update that pursuant to the proceedings under the Companies’ Creditors Arrangement Act (the “CCAA”) involving BioSteel Sports Nutrition Inc. (“BioSteel Canada”), the Ontario Superior Court of Justice (Commercial List) (“CCAA Court”) has approved two…